Adults with atopic dermatitis (AD) had a significantly higher prevalence of anxiety, depression, and obsessive-compulsive disorder (OCD) across all severities of the skin disorder, a large retrospective analysis showed. The strongest association was with OCD, which occurred almost 50% more often in patients with AD. Anxiety and depression were more modestly elevated (14% higher) but…

The rapid transition to virtual care that occurred with the onset of the COVID-19 pandemic resulted in better continuity of psychotherapy visits compared to prior to the pandemic when almost all visits were in-person, according to new research published in Psychiatric Services. In addition, the time between appointments grew shorter after the transition to virtual…

Over the past 40 years, the number of students in special education has doubled due to better identification and less stigma, experts said.

OMAHA, Neb. (WOWT) – During an ongoing national shortage for drugs used to treat attention-deficit-hyperactivity disorder (ADHD), one manufacturer is suing the federal government. A New York-based law firm representing Ascent Pharmaceuticals, Inc. said the Drug Enforcement Administration is keeping its client from manufacturing generic prescriptions to treat ADHD.

The Biden administration on Friday extended flexibilities regarding controlled substances to be prescribed via telemedicine. The Drug Enforcement Administration (DEA) said in a notice it would allow providers to continue using telemedicine to prescribe certain controlled substances through the end of 2024.

Nearly 1 in 5 children receiving care in a pediatric headache clinic had significant attention difficulties yet lacked a diagnosis of attention-deficit/hyperactivity disorder (ADHD), according to a poster presented at the 52nd Child Neurology Society Annual Meeting in Vancouver, British Columbia, Canada.

Edward Krumpotich, a drug policy consultant based in Minnesota, was diagnosed with severe attention deficit hyperactivity disorder at age 15 — but he didn’t get help for it until he was 37. In the interim years he suffered from methamphetamine addiction, which he later realized was driven by attempts to self-medicate his untreated A.D.H.D. He…

WEDNESDAY, Oct. 11, 2023 (HealthDay News) — A medication already approved for excessive daytime sleepiness may help ease attention-deficit/hyperactivity disorder (ADHD) symptoms in adults who aren’t getting relief from available treatments, according to a small pilot study.

Key Takeaways: – Older drivers with ADHD are more likely to slam on the brakes, get distracted and crash, a large study confirms – Drivers with ADHD were followed for almost four years using in-vehicle tracking devices – Risk factors such as heightened anxiety can also affect performance behind the wheel, researchers say

Viral Jesus Episode 82 | University chaplain José Bourget’s adult ADHD diagnosis helped him see himself—and his God—in a different light.

FIT spoke to three adults who have been recently diagnosed with ADHD.

Doctors in England have been told not to prescribe ADHD drugs to new patients because of a national shortage, as charities warn that the supply problems are devastating for people living with the condition. A national patient safety alert from the Department of Health and Social Care said the shortages were down to a combination…